Among these inhibitors, (4-quinolinoyl)glycyl-2-cyanopyrrolidine-based FAPIs fabricated by Koen et al. showed the highest affinity for FAP and were further modified and developed by scientists into cancer theranostic probes (9). Here, FAP is linked to cancer.